Mechanism of Action Causing Macrocytosis in B12 Deficiency

Primary Pathophysiological Mechanism

Vitamin B12 deficiency causes macrocytosis primarily through impaired DNA synthesis, leading to disordered cell division, maturation arrest, and ineffective early erythropoiesis 1, 2
In vitamin B12 deficiency, DNA synthesis is significantly impaired while RNA and protein synthesis continue normally, creating an asynchrony between nuclear and cytoplasmic maturation 1, 2
This impairment leads to erythroblasts undergoing apoptosis during their rapid division phase in early erythropoiesis 1, 2
The result is ineffective erythropoiesis with maturation arrest, producing fewer but larger red blood cells (macrocytosis) 1, 2

B12 serves as a cofactor for methionine synthase, which transfers methyl groups to form methionine from homocysteine 3
This reaction is critical for the synthesis of purines and pyrimidines, which are essential building blocks for DNA 3
B12 deficiency creates a "methyl trap" where 5-methyltetrahydrofolate accumulates and cannot participate in one-carbon transfer reactions 3
This leads to functional folate deficiency even when folate levels appear normal, further impairing DNA synthesis 3, 4

Cognitive difficulties and memory impairment may result from myelin sheath damage and elevated homocysteine levels 3
Screening for B12 deficiency should include both serum B12 levels and functional markers like homocysteine and methylmalonic acid 4, 5
Patients with more than 20-30 cm of distal ileum resection require B12 supplementation, as this is the site of B12 absorption 5, 6

Parenteral B12 supplementation (1000 μg monthly) is the standard treatment for patients with ileal resection >20 cm 5, 6
Oral supplementation (1200-2400 μg daily) may be effective but is less established in clinical practice 5, 6
Concurrent folate supplementation may be necessary, especially in patients on medications like methotrexate or sulfasalazine that affect folate metabolism 4, 6

The World Health Organization recommends a daily allowance of 2.4 mcg of vitamin B-12 per day, with strict vegetarians and elderly individuals being at high risk for deficiency 7, 8
Serum B-12 <150 pmol/L indicates vitamin B-12 deficiency, and methylmalonic acid testing should be performed when B-12 levels are indeterminate or clinical suspicion remains high despite normal levels 7, 8
A blood MMA level >271 nmol/L favors vitamin B-12 deficiency, and up to 50% of patients with "normal" serum B-12 may have metabolic deficiency when measured by MMA 7, 8

Intramuscular vitamin B-12 administration (1000 mcg on days 1-10, then monthly) is effective for confirmed intrinsic factor deficiency or severe neurologic manifestations, as recommended by the American Journal of Hematology 9
Oral vitamin B-12 (1000-2000 mcg daily) is as effective as intramuscular administration for most patients, and treatment should continue until levels normalize, then maintenance therapy 9